Personalized Medicine & Treatments With PAML
June 25, 2014
Healthcare Solutions: Early testing that can save more lives
Advances in genome testing are helping to improve the outcomes for people who are battling cancer. There is cutting-edge technology offering more accurate diagnosis, and today’s technologies allow doctors to match treatments with each patient’s cancer. Dr. Francisco Velazquez from PAML joins us to explain.
Behind the Mystery is a special segment dedicated to revolutionizing the way the health care system works for those suffering from a rare and genetic disorder.
Behind the Mystery takes a closer look at one of the two types of Polycystic Kidney disease. Autosomal Dominant Polycystic Kidney Disease, or ADPKD, is a rare, genetic condition.
Behind the Mystery takes a closer look at Blastic Plasmacytoid Dendritic Cell Neoplasm, a rare disease that is often misdiagnosed and affects at least 500 to 1,000 patients each year in the U.S.